Australia flu 2026: triple winter threat, record deaths, and the vaccine gap

What just happened

The Australian Government’s ‘Vaccination is the best preparation’ campaign has launched for winter 2026, targeting the triple threat of influenza, COVID-19, and respiratory syncytial virus (RSV) — the three respiratory viruses that drive the most serious illness and death in the colder months, particularly among older Australians, people with chronic conditions, young children, and pregnant women.

The campaign backdrop is significant. In 2025, more than 1,700 Australians died from influenza — the highest influenza death toll recorded in the modern surveillance series, according to the Doherty Institute. To put that number in context: influenza now kills more Australians each year than road trauma does. This is not a theoretical risk that applies to someone else’s elderly relative in a distant aged care facility. It affects working-age adults with diabetes and heart disease, it affects infants, and it affects older parents in the same households as people who defer vaccination because they feel healthy.

The reported influenza case numbers early in the 2026 season are running below the same period in 2025 — which is genuinely encouraging. But surveillance data indicates that vaccination rates among high-risk groups remain lower than needed to translate that early-season advantage into a protected winter.

---

The both-and

Australia has better winter vaccination tools than at any previous point. The gap is uptake, not availability — and the gap is measurable in the death toll.

The 2026 vaccine is different — what changed and why

This year’s flu vaccine is trivalent, not quadrivalent. The TGA’s 2026 seasonal influenza vaccines report confirms that the B/Yamagata influenza B lineage has been removed from the formulation entirely. The Yamagata lineage has not been detected circulating anywhere in the world since 2020 and has been declared globally eliminated by the WHO. The ATAGI recommendation and the TGA’s approved 2026 compositions reflect that reality: a three-strain vaccine targeting the two remaining influenza A subtypes (H1N1 and H3N2) and the currently circulating B/Victoria lineage.

A trivalent vaccine is not a downgrade. The concern would be if Yamagata re-emerged — which is not currently the case. The updated H1N1 and H3N2 components have been reformulated to match more recent circulating strains, following the 2025 season in which a novel H3N2 subclade contributed to an unusually prolonged and severe epidemic.

For children aged 2 to 17, FluMist — a nasal spray influenza vaccine — is available in 2026 as an alternative to needle-based administration. This is not a new product globally, but its availability in Australia expands options for families navigating needle-averse children.

What is free under the 2026 National Immunisation Programme

The Australian Immunisation Handbook is the authoritative reference for eligibility, but the broad picture for the 2026 season is:

Influenza vaccine — free under NIP for:

• All Australians aged 65 and over
• Pregnant women (any trimester)
• Aboriginal and Torres Strait Islander people aged 6 months and over
• Children aged 6 months to under 5 years
• People with chronic medical conditions that increase the risk of serious flu illness (including cardiovascular disease, respiratory conditions including asthma, diabetes, chronic kidney disease, and conditions affecting immunity)

RSV vaccine — free under NIP from May 2026 for:

• Adults aged 75 and over
• Aboriginal and Torres Strait Islander people aged 60 and over

COVID-19 boosters remain available but eligibility and subsidy vary — speak with your GP or pharmacist about what currently applies to your situation.

These vaccines can usually be accessed at your GP, a local pharmacy, or an Aboriginal Community Controlled Health Service. Combining appointments — flu and RSV in a single visit — is efficient and appropriate.

The uptake problem

The gap between who is eligible and who has actually received this season’s vaccines is where most of the preventable deaths sit. Fewer than 15% of high-risk Australians — defined as those with the chronic medical conditions that make flu potentially life-threatening — are current with all recommended winter vaccinations.

The Doherty Institute’s modelling is consistent on this point: if vaccine uptake in priority groups reached the government’s own targets, hundreds of deaths and tens of thousands of hospitalisations could be avoided each winter. The vaccines are free. The appointments are short. The evidence for benefit in high-risk groups is not contested — the sceptical arguments about flu vaccine efficacy apply primarily to healthy working-age adults, not to the populations in whom serious illness concentrates.

The uptake gap is partly habit (vaccination feels less urgent when you haven’t recently had a severe flu), partly health literacy (many people eligible for RSV vaccine don’t know RSV is now vaccine-preventable), and partly the structural challenge of getting people into a GP or pharmacy before they feel sick. The government campaign is trying to close all three of those gaps simultaneously.

---

2 cents

Winter started in June. If you are over 65, pregnant, living with a chronic health condition, or caring for someone in any of those groups — and you haven’t had this season’s flu vaccine — book it this week. The same appointment can usually address whether your COVID booster is current and whether RSV vaccination is right for you.

For families: children aged 6 months to under 5 years are a NIP priority group. Flu in this age group can cause serious illness. If your child’s immunisation is due or you’re unsure whether they’ve had this year’s flu vaccine, your GP or maternal and child health nurse is the right starting point.

This is general health information and does not constitute individual clinical advice.

---

Verdict

Verdict: yes — worth knowing about.

Australia enters winter 2026 with better vaccination tools than any previous year, a government campaign actively driving uptake, and a sobering 2025 death toll as the reference point. The 2026 flu vaccine is well-matched to circulating strains, RSV vaccination is now free for the oldest Australians, and the ask for anyone in a priority group is simple: make the appointment before July.

---

Sources cited

1. ‘Vaccination is the best preparation’ campaign — Australian Government Department of Health
2. Winter vaccinations — Australian Government Department of Health
3. What to expect from the 2026 flu season — Doherty Institute
4. 2026 Seasonal Influenza Vaccines — Therapeutic Goods Administration
5. Influenza — Australian Immunisation Handbook